98%
921
2 minutes
20
Objective: To examine the potential association between dietary index of gut microbiota (DI-GM) scores and constipation in adult women in the United States.
Methods: This cross-sectional study used data from adult participants in the 2005-2010 US National Health Survey (NHANES). The missing values in the covariables were filled by multiple interpolation. Multivariate logistic regression models were used to determine the odds ratios (OR) and 95% confidence intervals (CI) for the association between DI-GM and constipation. Subgroup analyses were also performed to examine the possible interactions between DI-GM and constipation.
Results: Of the 7,325 subjects, 887 reported constipations, with a prevalence of 12.1%. After adjustment for multivariate modeling, the DI-GM score was significantly associated with constipation (0.92 [95% CI 0.87-0.96]; = 0.001). Similar results were found for the association of beneficial gut microbiota score with constipation (OR 0.89 [95% CI 0.84 to 0.95]; = 0. 001). Subgroup analyses revealed that the relationship between DI-GM scores and constipation remained stable ( > 0.05).
Conclusion: DI-GM was negatively associated with the incidence of constipation in the female population. Clinicians should consider the influence of dietary structure on the treatment of constipation in women. Dietary intervention can be an important strategy for the comprehensive treatment of constipation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11997977 | PMC |
http://dx.doi.org/10.3389/fnut.2025.1562258 | DOI Listing |
Front Immunol
September 2025
Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Cancer is a multifaceted disease driven by a complex interplay of genetic predisposition, environmental factors and lifestyle habits. With the accelerating pace of cancer research, the gut microbiome has emerged as a critical modulator of human health and immunity. Disruption in the gut microbial populations and diversity, known as dysbiosis, has been linked with the development of chronic inflammation, oncogenesis, angiogenesis and metastasis.
View Article and Find Full Text PDFFront Immunol
September 2025
Guangxi Key Laboratory of AIDS Prevention and Treatment & School of Public Health, Guangxi Medical University, Nanning, Guangxi, China.
Background: People living with HIV(PLWH) are a high-risk population for cancer. We conducted a pioneering study on the gut microbiota of PLWH with various types of cancer, revealing key microbiota.
Methods: We collected stool samples from 54 PLWH who have cancer (PLWH-C), including Kaposi's sarcoma (KS, n=7), lymphoma (L, n=22), lung cancer (LC, n=12), and colorectal cancer (CRC, n=13), 55 PLWH who do not have cancer (PLWH-NC), and 49 people living without HIV (Ctrl).
Front Immunol
September 2025
Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
In the last decades, immunotherapy has revolutionized cancer treatment. Despite its success, a significant number of patients fail to respond, and the underlying causes of ineffectiveness remain poorly understood. Factors such as nutritional status and body composition are emerging as key predictors of immunotherapy outcomes.
View Article and Find Full Text PDFNat Sci Sleep
September 2025
Department of Respiratory Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
Background: Recent research has increasingly underscored a significant correlation between gut microbiota and obstructive sleep apnea (OSA). Probiotics have emerged as promising adjunctive interventions for OSA. Metabolites and their related biochemical pathways have emerged as important contributors to the development of OSA.
View Article and Find Full Text PDFFront Nutr
August 2025
Emergency Department, The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang City, Guizhou Province, China.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a rising health issue linked to poor diet and gut microbiota dysbiosis. The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, high in polyphenols and anti-inflammatory nutrients, may help protect against MASLD. This study examined how adherence to the MIND diet relates to MASLD severity, focusing on hepatic steatosis, fibrosis, insulin resistance, inflammation, and gut microbiota diversity.
View Article and Find Full Text PDF